Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

33.33
+3.9013.25%
Post-market: 33.550.2194+0.66%19:49 EST
Volume:3.20M
Turnover:104.14M
Market Cap:2.13B
PE:-8.33
High:34.07
Open:29.10
Low:28.81
Close:29.43
52wk High:51.27
52wk Low:18.53
Shares:63.93M
Float Shares:42.92M
Volume Ratio:2.66
T/O Rate:7.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9990
EPS(LYR):-2.7500
ROE:-73.25%
ROA:-38.12%
PB:5.34
PE(LYR):-12.12

Loading ...

Vera Therapeutics Appoints James R. Meyers to Board of Directors

Reuters
·
15 hours ago

Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to Its Board of Directors

THOMSON REUTERS
·
15 hours ago

Optimistic Buy Rating for Vera Therapeutics Driven by Atacicept’s Commercial Potential and Favorable Valuation

TIPRANKS
·
Yesterday

Wells Fargo Keeps Their Buy Rating on Vera Therapeutics (VERA)

TIPRANKS
·
Yesterday

Buy Recommendation for Vera Therapeutics: Atacicept’s Market Potential and Efficacy Drive Positive Outlook

TIPRANKS
·
Yesterday

Vera Therapeutics Executive Makes a Noteworthy Stock Sale

TIPRANKS
·
Yesterday

Vera Therapeutics to Participate at Upcoming Investor Conferences

GlobeNewswire
·
Nov 24

Vera Therapeutics Q3 EPS USD -1.26 Vs. IBES Estimate USD -1.17

Reuters
·
Nov 20

Vera Therapeutics (VERA): Valuation Insights Following Positive Phase 3 Data, FDA Filing, and Yale Investment

Simply Wall St.
·
Nov 16

Vera Therapeutics (VERA) Is Up 12.5% After Atacicept BLA Filing and Positive Phase 3 Data

Simply Wall St.
·
Nov 15

Vera Therapeutics SVP Finance Joseph R. Young Reports Sale of Common Shares

Reuters
·
Nov 14

Stock Track | Vera Therapeutics Soars 7.48% on FDA Application for Kidney Disease Treatment Atacicept

Stock Track
·
Nov 10

Stock Track | Vera Therapeutics Soars 5.83% Pre-market on FDA Application for Kidney Disease Treatment

Stock Track
·
Nov 10

Vera Therapeutics to Present at TD Cowen Immunology & Inflammation Summit

Reuters
·
Nov 10

Vera Therapeutics Submits Kidney Disease Therapy Biologics License Application to FDA; Shares Up Pre-Bell

MT Newswires Live
·
Nov 10

Vera Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 10

Stock Track | Vera Therapeutics Soars 6.24% After-Hours on FDA Application for Breakthrough IgA Nephropathy Treatment

Stock Track
·
Nov 08

Vera Therapeutics submits BLA for atacicept to FDA

TIPRANKS
·
Nov 08

Vera Therapeutics Submits FDA Application for Atacicept in IgA Nephropathy

Reuters
·
Nov 08

Vera Therapeutics Submits Biologics License Application to U.S. FDA Through Accelerated Approval Program for Atacicept for the Treatment of Adults With Iga Nephropathy

THOMSON REUTERS
·
Nov 08